Short-term variability in measures of glycemia and implications for the classification of diabetes

Research output: Contribution to journalArticle

Abstract

Background: Short-term variability in measures of glycemia has important implications for the diagnosis of diabetes mellitus and the conduct and interpretation of epidemiologic studies. Our objectives were to characterize the within-person variability in fasting glucose, 2-hour glucose, and hemoglobin A1c (HbA1c) levels and to assess the impact of using repeated measurements for classification of diabetes. Methods:Weanalyzed repeated measurements from 685 fasting participants without diagnosed diabetes from the National Health and Nutrition Examination Survey III Second Examination, a substudy conducted from 1988 to 1994 in which repeated examinations were conducted approximately 2 weeks after the original examination. Results: Two-hour glucose levels had substantially more variability (within-person coefficient of variation [CV w],16.7%; 95% confidence interval [CI], 15.0 to 18.3) compared with either fasting glucose (CVw,5.7%; 95% CI, 5.3 to 6.1) or HbA 1c (CVw,3.6%; 95% CI, 3.2 to 4.0) levels. The proportion of persons with a fasting glucose level of 126 mg/dL or higher (to convert to millimoles per liter, multiply by 0.0555) on the first test who also had a second glucose level of 126 mg/dL or higher was 70.4% (95% CI, 49.8% to 86.2%). Results were similar using the 2-hour glucose cutoff point of 140 mg/dL or higher. The prevalence of undiagnosed diabetes using a single fasting glucose level of 126 mg/dL or higher was 3.7%. If a second fasting glucose level of 126 mg/dL or higher was used to confirm the diagnosis (American Diabetes Association guidelines), the prevalence decreased to 2.8% (95% CI, 1.5% to 4.0%), a 24.4% decrease. Conclusions: We found high variability in 2-hour glucose levels relative to fasting glucose levels and high variability in both of these relative to HbA1c levels. Our findings suggest that studies that strictly apply guidelines for the diagnosis of diabetes (2 glucose measurements) may arrive at substantially different prevalence estimates compared with studies that use only a single measurement.

Original languageEnglish (US)
Pages (from-to)1545-1551
Number of pages7
JournalArchives of Internal Medicine
Volume167
Issue number14
DOIs
StatePublished - Jul 23 2007

Fingerprint

Glucose
Fasting
Confidence Intervals
Hemoglobins
Guidelines
Nutrition Surveys
Type 2 Diabetes Mellitus
Epidemiologic Studies
Diabetes Mellitus

ASJC Scopus subject areas

  • Internal Medicine

Cite this

Short-term variability in measures of glycemia and implications for the classification of diabetes. / Selvin, Elizabeth; Crainiceanu, Ciprian M; Brancati, Frederick L.; Coresh, Josef.

In: Archives of Internal Medicine, Vol. 167, No. 14, 23.07.2007, p. 1545-1551.

Research output: Contribution to journalArticle

@article{1c801f824390471e9a2087742b2e7c91,
title = "Short-term variability in measures of glycemia and implications for the classification of diabetes",
abstract = "Background: Short-term variability in measures of glycemia has important implications for the diagnosis of diabetes mellitus and the conduct and interpretation of epidemiologic studies. Our objectives were to characterize the within-person variability in fasting glucose, 2-hour glucose, and hemoglobin A1c (HbA1c) levels and to assess the impact of using repeated measurements for classification of diabetes. Methods:Weanalyzed repeated measurements from 685 fasting participants without diagnosed diabetes from the National Health and Nutrition Examination Survey III Second Examination, a substudy conducted from 1988 to 1994 in which repeated examinations were conducted approximately 2 weeks after the original examination. Results: Two-hour glucose levels had substantially more variability (within-person coefficient of variation [CV w],16.7{\%}; 95{\%} confidence interval [CI], 15.0 to 18.3) compared with either fasting glucose (CVw,5.7{\%}; 95{\%} CI, 5.3 to 6.1) or HbA 1c (CVw,3.6{\%}; 95{\%} CI, 3.2 to 4.0) levels. The proportion of persons with a fasting glucose level of 126 mg/dL or higher (to convert to millimoles per liter, multiply by 0.0555) on the first test who also had a second glucose level of 126 mg/dL or higher was 70.4{\%} (95{\%} CI, 49.8{\%} to 86.2{\%}). Results were similar using the 2-hour glucose cutoff point of 140 mg/dL or higher. The prevalence of undiagnosed diabetes using a single fasting glucose level of 126 mg/dL or higher was 3.7{\%}. If a second fasting glucose level of 126 mg/dL or higher was used to confirm the diagnosis (American Diabetes Association guidelines), the prevalence decreased to 2.8{\%} (95{\%} CI, 1.5{\%} to 4.0{\%}), a 24.4{\%} decrease. Conclusions: We found high variability in 2-hour glucose levels relative to fasting glucose levels and high variability in both of these relative to HbA1c levels. Our findings suggest that studies that strictly apply guidelines for the diagnosis of diabetes (2 glucose measurements) may arrive at substantially different prevalence estimates compared with studies that use only a single measurement.",
author = "Elizabeth Selvin and Crainiceanu, {Ciprian M} and Brancati, {Frederick L.} and Josef Coresh",
year = "2007",
month = "7",
day = "23",
doi = "10.1001/archinte.167.14.1545",
language = "English (US)",
volume = "167",
pages = "1545--1551",
journal = "JAMA Internal Medicine",
issn = "2168-6106",
publisher = "American Medical Association",
number = "14",

}

TY - JOUR

T1 - Short-term variability in measures of glycemia and implications for the classification of diabetes

AU - Selvin, Elizabeth

AU - Crainiceanu, Ciprian M

AU - Brancati, Frederick L.

AU - Coresh, Josef

PY - 2007/7/23

Y1 - 2007/7/23

N2 - Background: Short-term variability in measures of glycemia has important implications for the diagnosis of diabetes mellitus and the conduct and interpretation of epidemiologic studies. Our objectives were to characterize the within-person variability in fasting glucose, 2-hour glucose, and hemoglobin A1c (HbA1c) levels and to assess the impact of using repeated measurements for classification of diabetes. Methods:Weanalyzed repeated measurements from 685 fasting participants without diagnosed diabetes from the National Health and Nutrition Examination Survey III Second Examination, a substudy conducted from 1988 to 1994 in which repeated examinations were conducted approximately 2 weeks after the original examination. Results: Two-hour glucose levels had substantially more variability (within-person coefficient of variation [CV w],16.7%; 95% confidence interval [CI], 15.0 to 18.3) compared with either fasting glucose (CVw,5.7%; 95% CI, 5.3 to 6.1) or HbA 1c (CVw,3.6%; 95% CI, 3.2 to 4.0) levels. The proportion of persons with a fasting glucose level of 126 mg/dL or higher (to convert to millimoles per liter, multiply by 0.0555) on the first test who also had a second glucose level of 126 mg/dL or higher was 70.4% (95% CI, 49.8% to 86.2%). Results were similar using the 2-hour glucose cutoff point of 140 mg/dL or higher. The prevalence of undiagnosed diabetes using a single fasting glucose level of 126 mg/dL or higher was 3.7%. If a second fasting glucose level of 126 mg/dL or higher was used to confirm the diagnosis (American Diabetes Association guidelines), the prevalence decreased to 2.8% (95% CI, 1.5% to 4.0%), a 24.4% decrease. Conclusions: We found high variability in 2-hour glucose levels relative to fasting glucose levels and high variability in both of these relative to HbA1c levels. Our findings suggest that studies that strictly apply guidelines for the diagnosis of diabetes (2 glucose measurements) may arrive at substantially different prevalence estimates compared with studies that use only a single measurement.

AB - Background: Short-term variability in measures of glycemia has important implications for the diagnosis of diabetes mellitus and the conduct and interpretation of epidemiologic studies. Our objectives were to characterize the within-person variability in fasting glucose, 2-hour glucose, and hemoglobin A1c (HbA1c) levels and to assess the impact of using repeated measurements for classification of diabetes. Methods:Weanalyzed repeated measurements from 685 fasting participants without diagnosed diabetes from the National Health and Nutrition Examination Survey III Second Examination, a substudy conducted from 1988 to 1994 in which repeated examinations were conducted approximately 2 weeks after the original examination. Results: Two-hour glucose levels had substantially more variability (within-person coefficient of variation [CV w],16.7%; 95% confidence interval [CI], 15.0 to 18.3) compared with either fasting glucose (CVw,5.7%; 95% CI, 5.3 to 6.1) or HbA 1c (CVw,3.6%; 95% CI, 3.2 to 4.0) levels. The proportion of persons with a fasting glucose level of 126 mg/dL or higher (to convert to millimoles per liter, multiply by 0.0555) on the first test who also had a second glucose level of 126 mg/dL or higher was 70.4% (95% CI, 49.8% to 86.2%). Results were similar using the 2-hour glucose cutoff point of 140 mg/dL or higher. The prevalence of undiagnosed diabetes using a single fasting glucose level of 126 mg/dL or higher was 3.7%. If a second fasting glucose level of 126 mg/dL or higher was used to confirm the diagnosis (American Diabetes Association guidelines), the prevalence decreased to 2.8% (95% CI, 1.5% to 4.0%), a 24.4% decrease. Conclusions: We found high variability in 2-hour glucose levels relative to fasting glucose levels and high variability in both of these relative to HbA1c levels. Our findings suggest that studies that strictly apply guidelines for the diagnosis of diabetes (2 glucose measurements) may arrive at substantially different prevalence estimates compared with studies that use only a single measurement.

UR - http://www.scopus.com/inward/record.url?scp=34547224132&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34547224132&partnerID=8YFLogxK

U2 - 10.1001/archinte.167.14.1545

DO - 10.1001/archinte.167.14.1545

M3 - Article

VL - 167

SP - 1545

EP - 1551

JO - JAMA Internal Medicine

JF - JAMA Internal Medicine

SN - 2168-6106

IS - 14

ER -